ID   CD11B_HUMAN             Reviewed;         795 AA.
AC   P21127; O95265; Q12817; Q12818; Q12819; Q12820; Q12822; Q8N530;
AC   Q9NZS5; Q9UBJ0; Q9UBQ1; Q9UBR0; Q9UNY2; Q9UP57; Q9UP58; Q9UP59;
DT   01-FEB-1991, integrated into UniProtKB/Swiss-Prot.
DT   19-SEP-2003, sequence version 3.
DT   15-MAR-2017, entry version 189.
DE   RecName: Full=Cyclin-dependent kinase 11B;
DE            EC=2.7.11.22;
DE   AltName: Full=Cell division cycle 2-like protein kinase 1;
DE            Short=CLK-1;
DE   AltName: Full=Cell division protein kinase 11B;
DE   AltName: Full=Galactosyltransferase-associated protein kinase p58/GTA;
DE   AltName: Full=PITSLRE serine/threonine-protein kinase CDC2L1;
DE   AltName: Full=p58 CLK-1;
GN   Name=CDK11B; Synonyms=CDC2L1, CDK11, PITSLREA, PK58;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 7), AND FUNCTION.
RC   TISSUE=Liver;
RX   PubMed=2217177; DOI=10.1073/pnas.87.19.7467;
RA   Bunnell B.A., Heath L.S., Adams D.E., Lahti J.M., Kidd V.J.;
RT   "Increased expression of a 58-kDa protein kinase leads to changes in
RT   the CHO cell cycle.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:7467-7471(1990).
RN   [2]
RP   ERRATUM, AND SEQUENCE REVISION.
RX   PubMed=2006197; DOI=10.1073/pnas.88.6.2612d;
RA   Bunnell B.A., Heath L.S., Adams D.E., Lahti J.M., Kidd V.J.;
RL   Proc. Natl. Acad. Sci. U.S.A. 88:2612-2612(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 7), AND VARIANT GLN-601.
RC   TISSUE=Hematopoietic;
RX   PubMed=1639388; DOI=10.1016/0888-7543(92)90132-C;
RA   Eipers P.G., Lahti J.M., Kidd V.J.;
RT   "Structure and expression of the human p58clk-1 protein kinase
RT   chromosomal gene.";
RL   Genomics 13:613-621(1992).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS SV1; 2; 3; 8 AND SV11), VARIANT
RP   CYS-57, TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=8195233;
RA   Xiang J., Lahti J.M., Grenet J.A., Easton J.B., Kidd V.J.;
RT   "Molecular cloning and expression of alternatively spliced PITSLRE
RT   protein kinase isoforms.";
RL   J. Biol. Chem. 269:15786-15794(1994).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS SV1; SV4; SV5; SV9;
RP   SV10 AND SV11), AND TISSUE SPECIFICITY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=9750192;
RA   Gururajan R., Lahti J.M., Grenet J.A., Easton J., Gruber I.,
RA   Ambros P.F., Kidd V.J.;
RT   "Duplication of a genomic region containing the Cdc2L1-2 and MMP21-22
RT   genes on human chromosome 1p36.3 and their linkage to D1Z2.";
RL   Genome Res. 8:929-939(1998).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SV11).
RC   TISSUE=Placenta;
RA   Govindan M.V., Warriar N.;
RL   Submitted (JUL-1999) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   INTERACTION WITH RNPS1.
RX   PubMed=9580558;
RA   Loyer P., Trembley J.H., Lahti J.M., Kidd V.J.;
RT   "The RNP protein, RNPS1, associates with specific isoforms of the
RT   p34cdc2-related PITSLRE protein kinases in vivo.";
RL   J. Cell Sci. 111:1495-1506(1998).
RN   [8]
RP   ALTERNATIVE INITIATION (ISOFORM 7), AND INDUCTION.
RX   PubMed=10882096; DOI=10.1016/S1097-2765(00)80239-7;
RA   Cornelis S., Bruynooghe Y., Denecker G., Van Huffel S., Tinton S.,
RA   Beyaert R.;
RT   "Identification and characterization of a novel cell cycle-regulated
RT   internal ribosome entry site.";
RL   Mol. Cell 5:597-605(2000).
RN   [9]
RP   INTERACTION WITH RANBP9, AUTOPHOSPHORYLATION, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=14511641; DOI=10.1016/j.bbrc.2003.08.116;
RA   Mikolajczyk M., Shi J., Vaillancourt R.R., Sachs N.A., Nelson M.;
RT   "The cyclin-dependent kinase 11(p46) isoform interacts with RanBPM.";
RL   Biochem. Biophys. Res. Commun. 310:14-18(2003).
RN   [10]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH CCNL1 AND SFRS7.
RX   PubMed=12501247; DOI=10.1074/jbc.M210057200;
RA   Hu D., Mayeda A., Trembley J.H., Lahti J.M., Kidd V.J.;
RT   "CDK11 complexes promote pre-mRNA splicing.";
RL   J. Biol. Chem. 278:8623-8629(2003).
RN   [11]
RP   FUNCTION, AND INTERACTION WITH PAK1.
RX   PubMed=12624090; DOI=10.1074/jbc.M300818200;
RA   Chen S., Yin X., Zhu X., Yan J., Ji S., Chen C., Cai M., Zhang S.,
RA   Zong H., Hu Y., Yuan Z., Shen Z., Gu J.;
RT   "The C-terminal kinase domain of the p34cdc2-related PITSLRE protein
RT   kinase (p110C) associates with p21-activated kinase 1 and inhibits its
RT   activity during anoikis.";
RL   J. Biol. Chem. 278:20029-20036(2003).
RN   [12]
RP   PHOSPHORYLATION AT SER-115.
RX   PubMed=15883043; DOI=10.1016/j.bbrc.2005.04.078;
RA   Feng Y., Qi W., Martinez J., Nelson M.A.;
RT   "The cyclin-dependent kinase 11 interacts with 14-3-3 proteins.";
RL   Biochem. Biophys. Res. Commun. 331:1503-1509(2005).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-595, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [15]
RP   PHOSPHORYLATION AT SER-482 AND THR-488 BY CDK7.
RX   PubMed=16327805; DOI=10.1038/nsmb1028;
RA   Larochelle S., Batliner J., Gamble M.J., Barboza N.M., Kraybill B.C.,
RA   Blethrow J.D., Shokat K.M., Fisher R.P.;
RT   "Dichotomous but stringent substrate selection by the dual-function
RT   Cdk7 complex revealed by chemical genetics.";
RL   Nat. Struct. Mol. Biol. 13:55-62(2006).
RN   [16]
RP   FUNCTION, AND INTERACTION WITH CCNL1 AND CCNL2.
RX   PubMed=18216018; DOI=10.1074/jbc.M708188200;
RA   Loyer P., Trembley J.H., Grenet J.A., Busson A., Corlu A., Zhao W.,
RA   Kocak M., Kidd V.J., Lahti J.M.;
RT   "Characterization of cyclin L1 and L2 interactions with CDK11 and
RT   splicing factors: influence of cyclin L isoforms on splice site
RT   selection.";
RL   J. Biol. Chem. 283:7721-7732(2008).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-594 AND THR-595, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-589 AND THR-595, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-595, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-595, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-595, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [23]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [24]
RP   INTERACTION WITH MYO18A.
RX   PubMed=25965346; DOI=10.1371/journal.pone.0126576;
RA   Yang L., Carrillo M., Wu Y.M., DiAngelo S.L., Silveyra P.,
RA   Umstead T.M., Halstead E.S., Davies M.L., Hu S., Floros J.,
RA   McCormack F.X., Christensen N.D., Chroneos Z.C.;
RT   "SP-R210 (Myo18A) isoforms as intrinsic modulators of macrophage
RT   priming and activation.";
RL   PLoS ONE 10:E0126576-E0126576(2015).
RN   [25]
RP   VARIANTS [LARGE SCALE ANALYSIS] CYS-57; TRP-201; LEU-414; ALA-452;
RP   VAL-463; SER-506; GLN-601; ASN-641 AND VAL-670.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Plays multiple roles in cell cycle progression,
CC       cytokinesis and apoptosis. Involved in pre-mRNA splicing in a
CC       kinase activity-dependent manner. Isoform 7 may act as a negative
CC       regulator of normal cell cycle progression.
CC       {ECO:0000269|PubMed:12501247, ECO:0000269|PubMed:12624090,
CC       ECO:0000269|PubMed:18216018, ECO:0000269|PubMed:2217177}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC   -!- ENZYME REGULATION: Phosphorylation at Thr-448 or Tyr-449
CC       inactivates the enzyme, while phosphorylation at Thr-595 activates
CC       it. {ECO:0000250}.
CC   -!- SUBUNIT: Cleaved isoform SV9 (p110C) binds to the serine/threonine
CC       kinase PAK1 and RANBP9. p110C interacts with RNPS1. Isoform 7, but
CC       not isoform SV9, nor its cleavage product p110C, interacts with
CC       CCND3. Interacts with CCNL1 and CCNL2. Forms complexes with pre-
CC       mRNA-splicing factors, including at least SRSF1, SRSF2 AND
CC       SRSF7/SLU7. Interacts with isoform 5 of MYO18A (PubMed:25965346).
CC       {ECO:0000269|PubMed:12501247, ECO:0000269|PubMed:12624090,
CC       ECO:0000269|PubMed:14511641, ECO:0000269|PubMed:25965346,
CC       ECO:0000269|PubMed:9580558}.
CC   -!- INTERACTION:
CC       O00303:EIF3F; NbExp=3; IntAct=EBI-1298, EBI-711990;
CC       Q13153:PAK1; NbExp=4; IntAct=EBI-1298, EBI-1307;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing, Alternative initiation; Named isoforms=10;
CC       Name=SV9; Synonyms=CDK11-p110;
CC         IsoId=P21127-1; Sequence=Displayed;
CC       Name=SV1; Synonyms=Alpha 2-1;
CC         IsoId=P21127-2; Sequence=VSP_008280;
CC       Name=2; Synonyms=Alpha 2-2;
CC         IsoId=P21127-3; Sequence=VSP_008278, VSP_008279, VSP_008280;
CC       Name=3; Synonyms=Alpha 1;
CC         IsoId=P21127-4; Sequence=VSP_008276;
CC       Name=SV4;
CC         IsoId=P21127-5; Sequence=VSP_008275;
CC       Name=SV5;
CC         IsoId=P21127-6; Sequence=VSP_008273, VSP_008277, VSP_008278,
CC                                  VSP_008280;
CC       Name=8; Synonyms=Alpha 2-3;
CC         IsoId=P21127-8; Sequence=VSP_008278, VSP_008280;
CC       Name=SV10;
CC         IsoId=P21127-9; Sequence=VSP_008273, VSP_008277, VSP_008280;
CC       Name=SV11; Synonyms=Alpha 2-4;
CC         IsoId=P21127-10; Sequence=VSP_008274, VSP_008280;
CC       Name=7; Synonyms=CDK11-p58;
CC         IsoId=P21127-12; Sequence=VSP_018834;
CC         Note=Produced by alternative initiation at Met-357 of isoform
CC         SV9 via an internal ribosomal entry site (IRES).;
CC   -!- TISSUE SPECIFICITY: Expressed ubiquitously. Some evidence of
CC       isoform-specific tissue distribution. {ECO:0000269|PubMed:8195233,
CC       ECO:0000269|PubMed:9750192}.
CC   -!- INDUCTION: Isoform 7 is induced in G2/M phase of the cell cycle.
CC       {ECO:0000269|PubMed:10882096}.
CC   -!- PTM: During FAS- or TNF-induced apoptosis, isoform SV9 is cleaved
CC       by caspases to produce p110C, a fragment that contains the C-
CC       terminal kinase domain.
CC   -!- PTM: Phosphorylation at Ser-115 creates a binding site for 14-3-3
CC       proteins. p110C can be autophosphorylated.
CC       {ECO:0000269|PubMed:15883043, ECO:0000269|PubMed:16327805}.
CC   -!- MISCELLANEOUS: Duplicated gene. CDK11A and CDK11B encode almost
CC       identical protein kinases of 110 kDa that contain at their C-
CC       termini the open reading frame of a smaller 58 kDa isoform which
CC       is expressed following IRES-mediated alternative initiation of
CC       translation.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC
CC       Ser/Thr protein kinase family. CDC2/CDKX subfamily. {ECO:0000305}.
CC   -!- CAUTION: Many references talk about 'p110 isoforms' but it is not
CC       yet known if this refers to CDK11A and/or CDK11B or one/some of
CC       the isoforms of each. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC83664.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=AAF36538.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M37712; AAA36406.1; ALT_SEQ; mRNA.
DR   EMBL; M88563; AAB59449.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; M88553; AAB59449.1; JOINED; Genomic_DNA.
DR   EMBL; M88554; AAB59449.1; JOINED; Genomic_DNA.
DR   EMBL; M88555; AAB59449.1; JOINED; Genomic_DNA.
DR   EMBL; M88558; AAB59449.1; JOINED; Genomic_DNA.
DR   EMBL; M88559; AAB59449.1; JOINED; Genomic_DNA.
DR   EMBL; M88560; AAB59449.1; JOINED; Genomic_DNA.
DR   EMBL; M88561; AAB59449.1; JOINED; Genomic_DNA.
DR   EMBL; M88562; AAB59449.1; JOINED; Genomic_DNA.
DR   EMBL; U04815; AAA19581.1; -; mRNA.
DR   EMBL; U04816; AAA19582.1; -; mRNA.
DR   EMBL; U04817; AAA19583.1; -; mRNA.
DR   EMBL; U04818; AAA19584.1; -; mRNA.
DR   EMBL; U04824; AAA19586.1; -; mRNA.
DR   EMBL; AF067512; AAC72077.1; -; mRNA.
DR   EMBL; AF067513; AAC72078.1; -; mRNA.
DR   EMBL; AF067514; AAC72079.1; -; mRNA.
DR   EMBL; AF067515; AAC72080.1; -; mRNA.
DR   EMBL; AF067516; AAC72081.1; -; mRNA.
DR   EMBL; AF067517; AAC72082.1; -; mRNA.
DR   EMBL; AF080683; AAC83662.1; -; Genomic_DNA.
DR   EMBL; AF080685; AAC83662.1; JOINED; Genomic_DNA.
DR   EMBL; AF080686; AAC83662.1; JOINED; Genomic_DNA.
DR   EMBL; AF080687; AAC83662.1; JOINED; Genomic_DNA.
DR   EMBL; AF080688; AAC83662.1; JOINED; Genomic_DNA.
DR   EMBL; AF092429; AAC83662.1; JOINED; Genomic_DNA.
DR   EMBL; AF092430; AAC83662.1; JOINED; Genomic_DNA.
DR   EMBL; AF080678; AAC83662.1; JOINED; Genomic_DNA.
DR   EMBL; AF080679; AAC83662.1; JOINED; Genomic_DNA.
DR   EMBL; AF080680; AAC83662.1; JOINED; Genomic_DNA.
DR   EMBL; AF080681; AAC83662.1; JOINED; Genomic_DNA.
DR   EMBL; AF080682; AAC83662.1; JOINED; Genomic_DNA.
DR   EMBL; AF080683; AAC83663.1; -; Genomic_DNA.
DR   EMBL; AF080685; AAC83663.1; JOINED; Genomic_DNA.
DR   EMBL; AF080686; AAC83663.1; JOINED; Genomic_DNA.
DR   EMBL; AF080687; AAC83663.1; JOINED; Genomic_DNA.
DR   EMBL; AF080688; AAC83663.1; JOINED; Genomic_DNA.
DR   EMBL; AF092429; AAC83663.1; JOINED; Genomic_DNA.
DR   EMBL; AF092430; AAC83663.1; JOINED; Genomic_DNA.
DR   EMBL; AF080678; AAC83663.1; JOINED; Genomic_DNA.
DR   EMBL; AF080679; AAC83663.1; JOINED; Genomic_DNA.
DR   EMBL; AF080680; AAC83663.1; JOINED; Genomic_DNA.
DR   EMBL; AF080681; AAC83663.1; JOINED; Genomic_DNA.
DR   EMBL; AF080682; AAC83663.1; JOINED; Genomic_DNA.
DR   EMBL; AF080683; AAC83664.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AF080685; AAC83664.1; JOINED; Genomic_DNA.
DR   EMBL; AF080686; AAC83664.1; JOINED; Genomic_DNA.
DR   EMBL; AF080687; AAC83664.1; JOINED; Genomic_DNA.
DR   EMBL; AF080688; AAC83664.1; JOINED; Genomic_DNA.
DR   EMBL; AF092429; AAC83664.1; JOINED; Genomic_DNA.
DR   EMBL; AF092430; AAC83664.1; JOINED; Genomic_DNA.
DR   EMBL; AF080678; AAC83664.1; JOINED; Genomic_DNA.
DR   EMBL; AF080679; AAC83664.1; JOINED; Genomic_DNA.
DR   EMBL; AF080680; AAC83664.1; JOINED; Genomic_DNA.
DR   EMBL; AF080681; AAC83664.1; JOINED; Genomic_DNA.
DR   EMBL; AF080682; AAC83664.1; JOINED; Genomic_DNA.
DR   EMBL; AF080683; AAC83665.1; -; Genomic_DNA.
DR   EMBL; AF080685; AAC83665.1; JOINED; Genomic_DNA.
DR   EMBL; AF080686; AAC83665.1; JOINED; Genomic_DNA.
DR   EMBL; AF080687; AAC83665.1; JOINED; Genomic_DNA.
DR   EMBL; AF080688; AAC83665.1; JOINED; Genomic_DNA.
DR   EMBL; AF092429; AAC83665.1; JOINED; Genomic_DNA.
DR   EMBL; AF092430; AAC83665.1; JOINED; Genomic_DNA.
DR   EMBL; AF080678; AAC83665.1; JOINED; Genomic_DNA.
DR   EMBL; AF080679; AAC83665.1; JOINED; Genomic_DNA.
DR   EMBL; AF080680; AAC83665.1; JOINED; Genomic_DNA.
DR   EMBL; AF080681; AAC83665.1; JOINED; Genomic_DNA.
DR   EMBL; AF080682; AAC83665.1; JOINED; Genomic_DNA.
DR   EMBL; AF080683; AAC83666.1; -; Genomic_DNA.
DR   EMBL; AF092430; AAC83666.1; JOINED; Genomic_DNA.
DR   EMBL; AF080678; AAC83666.1; JOINED; Genomic_DNA.
DR   EMBL; AF080679; AAC83666.1; JOINED; Genomic_DNA.
DR   EMBL; AF080680; AAC83666.1; JOINED; Genomic_DNA.
DR   EMBL; AF080681; AAC83666.1; JOINED; Genomic_DNA.
DR   EMBL; AF080682; AAC83666.1; JOINED; Genomic_DNA.
DR   EMBL; AF174497; AAF36538.1; ALT_INIT; mRNA.
DR   CCDS; CCDS72682.1; -. [P21127-9]
DR   CCDS; CCDS72683.1; -. [P21127-1]
DR   CCDS; CCDS72684.1; -. [P21127-2]
DR   PIR; A38282; A38282.
DR   PIR; B54024; B54024.
DR   PIR; E54024; E54024.
DR   PIR; F54024; F54024.
DR   PIR; H54024; H54024.
DR   PIR; T09568; T09568.
DR   RefSeq; NP_277022.1; NM_033487.2. [P21127-5]
DR   RefSeq; NP_277025.1; NM_033490.2. [P21127-10]
DR   UniGene; Hs.651228; -.
DR   UniGene; Hs.709182; -.
DR   ProteinModelPortal; P21127; -.
DR   SMR; P21127; -.
DR   BioGrid; 107421; 41.
DR   IntAct; P21127; 16.
DR   MINT; MINT-1400900; -.
DR   STRING; 9606.ENSP00000384442; -.
DR   BindingDB; P21127; -.
DR   ChEMBL; CHEMBL5808; -.
DR   GuidetoPHARMACOLOGY; 1964; -.
DR   iPTMnet; P21127; -.
DR   PhosphoSitePlus; P21127; -.
DR   BioMuta; CDK11B; -.
DR   DMDM; 34978359; -.
DR   EPD; P21127; -.
DR   MaxQB; P21127; -.
DR   PaxDb; P21127; -.
DR   PeptideAtlas; P21127; -.
DR   PRIDE; P21127; -.
DR   DNASU; 984; -.
DR   GeneID; 984; -.
DR   KEGG; hsa:984; -.
DR   CTD; 984; -.
DR   DisGeNET; 984; -.
DR   GeneCards; CDK11B; -.
DR   HGNC; HGNC:1729; CDK11B.
DR   HPA; HPA025061; -.
DR   HPA; HPA073626; -.
DR   MIM; 176873; gene.
DR   neXtProt; NX_P21127; -.
DR   PharmGKB; PA26262; -.
DR   eggNOG; KOG0663; Eukaryota.
DR   eggNOG; ENOG410XQ50; LUCA.
DR   HOVERGEN; HBG014652; -.
DR   InParanoid; P21127; -.
DR   KO; K08818; -.
DR   PhylomeDB; P21127; -.
DR   BRENDA; 2.7.11.22; 2681.
DR   Reactome; R-HSA-380270; Recruitment of mitotic centrosome proteins and complexes.
DR   SignaLink; P21127; -.
DR   SIGNOR; P21127; -.
DR   ChiTaRS; CDK11B; human.
DR   GeneWiki; CDC2L1; -.
DR   GenomeRNAi; 984; -.
DR   PMAP-CutDB; P21127; -.
DR   PRO; PR:P21127; -.
DR   Proteomes; UP000005640; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0004693; F:cyclin-dependent protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0004672; F:protein kinase activity; TAS:ProtInc.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0006915; P:apoptotic process; NAS:UniProtKB.
DR   GO; GO:0008283; P:cell proliferation; TAS:ProtInc.
DR   GO; GO:0007067; P:mitotic nuclear division; NAS:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0001558; P:regulation of cell growth; IEP:UniProtKB.
DR   GO; GO:0007346; P:regulation of mitotic cell cycle; IBA:GO_Central.
DR   GO; GO:0050684; P:regulation of mRNA processing; IDA:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative initiation; Alternative splicing; Apoptosis; ATP-binding;
KW   Cell cycle; Complete proteome; Cytoplasm; Kinase; Nucleotide-binding;
KW   Nucleus; Phosphoprotein; Polymorphism; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    795       Cyclin-dependent kinase 11B.
FT                                /FTId=PRO_0000024311.
FT   DOMAIN      438    723       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     444    452       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   COMPBIAS    126    393       Glu-rich.
FT   ACT_SITE    562    562       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING     467    467       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES      47     47       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P24788}.
FT   MOD_RES      72     72       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P24788}.
FT   MOD_RES     115    115       Phosphoserine.
FT                                {ECO:0000269|PubMed:15883043}.
FT   MOD_RES     283    283       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P24788}.
FT   MOD_RES     482    482       Phosphoserine; by CDK7.
FT                                {ECO:0000269|PubMed:16327805}.
FT   MOD_RES     488    488       Phosphothreonine; by CDK7.
FT                                {ECO:0000269|PubMed:16327805}.
FT   MOD_RES     589    589       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     594    594       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     595    595       Phosphothreonine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     751    751       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P24788}.
FT   MOD_RES     752    752       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P24788}.
FT   VAR_SEQ       1    356       Missing (in isoform 7).
FT                                {ECO:0000303|PubMed:2217177}.
FT                                /FTId=VSP_018834.
FT   VAR_SEQ       1    269       Missing (in isoform SV4).
FT                                {ECO:0000303|PubMed:9750192}.
FT                                /FTId=VSP_008275.
FT   VAR_SEQ       1    217       Missing (in isoform SV11).
FT                                {ECO:0000303|PubMed:8195233,
FT                                ECO:0000303|PubMed:9750192,
FT                                ECO:0000303|Ref.6}.
FT                                /FTId=VSP_008274.
FT   VAR_SEQ       1     34       Missing (in isoform SV5 and isoform
FT                                SV10). {ECO:0000303|PubMed:9750192}.
FT                                /FTId=VSP_008273.
FT   VAR_SEQ       2    335       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:8195233}.
FT                                /FTId=VSP_008276.
FT   VAR_SEQ      35     37       LKN -> MSQ (in isoform SV5 and isoform
FT                                SV10). {ECO:0000303|PubMed:9750192}.
FT                                /FTId=VSP_008277.
FT   VAR_SEQ     110    119       Missing (in isoform 2, isoform SV5 and
FT                                isoform 8). {ECO:0000303|PubMed:8195233,
FT                                ECO:0000303|PubMed:9750192}.
FT                                /FTId=VSP_008278.
FT   VAR_SEQ     165    165       R -> RGNDGVCLFR (in isoform 2).
FT                                {ECO:0000303|PubMed:8195233}.
FT                                /FTId=VSP_008279.
FT   VAR_SEQ     252    265       GEARPARAQKPAQL -> V (in isoform SV1,
FT                                isoform 2, isoform SV5, isoform 8,
FT                                isoform SV10 and isoform SV11).
FT                                {ECO:0000303|PubMed:8195233,
FT                                ECO:0000303|PubMed:9750192,
FT                                ECO:0000303|Ref.6}.
FT                                /FTId=VSP_008280.
FT   VARIANT      57     57       R -> C (in dbSNP:rs17424353).
FT                                {ECO:0000269|PubMed:17344846,
FT                                ECO:0000269|PubMed:8195233}.
FT                                /FTId=VAR_041958.
FT   VARIANT      93     93       R -> W (in dbSNP:rs1059831).
FT                                /FTId=VAR_057775.
FT   VARIANT     109    109       R -> C (in dbSNP:rs1059830).
FT                                /FTId=VAR_062199.
FT   VARIANT     201    201       R -> W. {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041959.
FT   VARIANT     414    414       S -> L. {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041960.
FT   VARIANT     452    452       V -> A. {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_045577.
FT   VARIANT     463    463       I -> V. {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041961.
FT   VARIANT     506    506       G -> S. {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_045578.
FT   VARIANT     601    601       L -> Q. {ECO:0000269|PubMed:1639388,
FT                                ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041962.
FT   VARIANT     641    641       K -> N. {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041963.
FT   VARIANT     670    670       A -> V (in dbSNP:rs1059811).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041964.
FT   CONFLICT    109    109       Missing (in Ref. 4; AAA19582/AAA19583 and
FT                                5; AAC72079). {ECO:0000305}.
FT   CONFLICT    126    126       E -> K (in Ref. 4; AAA19582/AAA19583/
FT                                AAA19586). {ECO:0000305}.
FT   CONFLICT    320    320       S -> T (in Ref. 6). {ECO:0000305}.
FT   CONFLICT    324    326       Missing (in Ref. 4; AAA19582/AAA19583/
FT                                AAA19584/AAA19586). {ECO:0000305}.
FT   CONFLICT    436    436       E -> D (in Ref. 3). {ECO:0000305}.
FT   CONFLICT    560    560       H -> Q (in Ref. 6). {ECO:0000305}.
FT   CONFLICT    567    567       N -> T (in Ref. 6). {ECO:0000305}.
FT   CONFLICT    678    678       E -> R (in Ref. 4 and 6). {ECO:0000305}.
FT   CONFLICT    694    694       D -> E (in Ref. 3). {ECO:0000305}.
FT   CONFLICT    697    697       F -> C (in Ref. 6). {ECO:0000305}.
FT   CONFLICT    712    712       I -> L (in Ref. 3). {ECO:0000305}.
FT   CONFLICT    715    715       E -> Q (in Ref. 3). {ECO:0000305}.
FT   CONFLICT    792    792       S -> R (in Ref. 6). {ECO:0000305}.
SQ   SEQUENCE   795 AA;  92707 MW;  C07CEE9A4F7A6804 CRC64;
     MGDEKDSWKV KTLDEILQEK KRRKEQEEKA EIKRLKNSDD RDSKRDSLEE GELRDHRMEI
     TIRNSPYRRE DSMEDRGEED DSLAIKPPQQ MSRKEKVHHR KDEKRKEKRR HRSHSAEGGK
     HARVKEKERE HERRKRHREE QDKARREWER QKRREMAREH SRRERDRLEQ LERKRERERK
     MREQQKEQRE QKERERRAEE RRKEREARRE VSAHHRTMRE DYSDKVKASH WSRSPPRPPR
     ERFELGDGRK PGEARPARAQ KPAQLKEEKM EERDLLSDLQ DISDSERKTS SAESSSAESG
     SGSEEEEEEE EEEEEEGSTS EESEEEEEEE EEEEEETGSN SEEASEQSAE EVSEEEMSED
     EERENENHLL VVPESRFDRD SGESEEAEEE VGEGTPQSSA LTEGDYVPDS PALSPIELKQ
     ELPKYLPALQ GCRSVEEFQC LNRIEEGTYG VVYRAKDKKT DEIVALKRLK MEKEKEGFPI
     TSLREINTIL KAQHPNIVTV REIVVGSNMD KIYIVMNYVE HDLKSLMETM KQPFLPGEVK
     TLMIQLLRGV KHLHDNWILH RDLKTSNLLL SHAGILKVGD FGLAREYGSP LKAYTPVVVT
     LWYRAPELLL GAKEYSTAVD MWSVGCIFGE LLTQKPLFPG KSEIDQINKV FKDLGTPSEK
     IWPGYSELPA VKKMTFSEHP YNNLRKRFGA LLSDQGFDLM NKFLTYFPGR RISAEDGLKH
     EYFRETPLPI DPSMFPTWPA KSEQQRVKRG TSPRPPEGGL GYSQLGDDDL KETGFHLTTT
     NQGASAAGPG FSLKF
//
